PUBLIC COMPANY
saveSURGE Therapeutics Inc
updated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery
- phase1Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
- phase2A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- phase1SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
🐶 Hiring Signal
News
- Citing Replimune approval, experts say localized cancer meds could redefine careDelivering therapeutics directly to tumors, as in the case of Replimune’s recently approved Tudriqev and Amgen’s Imlygic, holds advantages, especially when cancer is caught early, but challenges re…biospace · 10d ago
comments(0)
5-min edit window · permanent after that